ArticleDrugs - real world outcomes2023

Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens.

Elizabeth Marrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.